| Seroquel Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Seroquel 100 mg | tablet | oral | 1.0 each | OTC |
| Seroquel 400 mg | tablet | oral | 1.0 each | OTC |
| Seroquel 200 mg | tablet | oral | 1.0 each | OTC |
| Seroquel 50 mg | tablet | oral | 1.0 each | OTC |
| Seroquel 25 mg | tablet | oral | 1.0 each | OTC |
| Seroquel 300 mg | tablet | oral | 1.0 each | OTC |
Posted by jennifer6791 3 days ago
started taking seoquel 25 mg an hour before sleep, then 50 mg. went up to 75mg because i wasn't "tired" enough to sleep. it...
Posted by jaymaster 11 days ago
ive been on seroquel for about three months...low dose,,,25 mg to 50 a day,,,ive noticed im an emotionless zombie,,,my concen...
Posted by texasnvs 13 days ago
Hi,
I am bipolar and have schizo affective disorder too. My doctor has been working with me for 3 years now trying to fin...
RPT BROKERWATCH AstraZeneca target price cut to 2100 pence from ... - Euro2day
In a note to clients this morning, HSBC said its base case scenario for valuation is six month generic competition for Seroquel and Nexium in the US in ...
Fri Mar 07 05:03:41 -0500 2008
AstraZeneca Submits Seroquel XR™ in Europe for the Treatment of ... - PR-USA.net (press release)
AstraZeneca also announced it has submitted a further application in the EU for SEROQUEL® (quetiapine fumarate immediate release, IR) for the treatment of ...
Tue Mar 04 14:16:52 -0500 2008
AstraZeneca Seeks Additional Indication for Seroquel XR - FDA news (subscription)
AstraZeneca has submitted a supplemental new drug application to the FDA for once-daily Seroquel extended-release (XR) tablets to treat major depressive ...
Tue Mar 04 17:32:10 -0500 2008
quetiapine fumarate - The fumarate salt form of quetiapine, a dibenzothiazepine derivative with antipsychotic property. Quetiapine fumarate antagonizes serotonin activity mediated by 5-HT 1A and 5-HT2 receptors. With a lower affinity, this agent also reversibly binds to dopamine D1 and D2 receptors in the mesolimbic and mesocortical areas of the brain leading to decreased psychotic effects, such as hallucinations and delusions. In addition, quetiapine fumarate also binds to other alpha1, alpha2 adrenergic and histamine H1 receptors.